<DOC>
	<DOCNO>NCT00047814</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability pharmacokinetics 4 week therapy FK788 subject chronic hepatitis C virus ( HCV ) infection . Also , assess effect FK788 serum ALT concentration hepatitis C viral level therapy four week follow therapy .</brief_summary>
	<brief_title>Study FK788 Subjects With Chronic Hepatitis C Virus Infection</brief_title>
	<detailed_description>This multi-center , randomize , investigator subject blind , placebo-controlled eight week study , include four week treatment period four week follow-up period . Three cohort HCV positive subject study sequential manner .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<criteria>The following criterion brief summary Criterion require trial participation . Inclusion Criteria Has chronic hepatitis C virus infection previously receive least three month treatment approve therapy fail respond , relapse tolerate therapy Has positive HCV RNA RTPCR Has abnormal ALT level ( least 2 X ULN ) Has liver biopsy within past 2 year consistent chronic hepatitis , evidence nonalcoholic steatohepatitis cirrhosis , least mild inflammation Has normal liver function indicate : PT = &lt; 2 sec . prolong compare ULN , Albumin &gt; = 3.5 g/dL , Total bilirubin = &lt; 1.5 mg/dL ANA titer = &lt; 1:160 Exclusion Criteria Has positive skin test tuberculosis Has ALT value &gt; = 300 IU/L Has abnormal hematological parameter indicate : ANC &lt; 1500/mm3 Platelets &lt; 100,000/mm3 Has creatinine &gt; 1.5 X ULN AFP &gt; 50 ng/mL evidence hepatocellular carcinoma ultrasound Is carrier hepatitis B surface antigen ( HBsAg ) , positive HIV1 and/or HIV2 antibody</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>HCV</keyword>
</DOC>